Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.

Am J Respir Crit Care Med · 2020 · PMC7068837 · PMID 31841044

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

a nonsignificant trendP = 0.08so close (0.05 < p ≤ 0.1)

Compared with placebo, study intervention showed a nonsignificant trend toward improving FVC (treatment difference, 4.19%; P = 0.08) ( 34 ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.